PARD (Poniard Pharmaceuticals) Stock Based Compensation: $4.05 Mil (TTM As of Sep. 2011)


What is Poniard Pharmaceuticals Stock Based Compensation?

Poniard Pharmaceuticals PARD Stock Based Compensation is $4.05 Mil as of Sep. 2011.

Poniard Pharmaceuticals's Stock Based Compensation for the three months ended in Sep. 2011 was $0.65 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2011 was $4.05 Mil.

Poniard Pharmaceuticals Stock Based Compensation Related Terms

Poniard Pharmaceuticals Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Poniard Pharmaceuticals's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Stock Based Compensation Chart

Poniard Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 7.12 7.29 8.91

Poniard Pharmaceuticals Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.57 1.54 1.00 0.85 0.65

Poniard Pharmaceuticals Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.05 Mil.

What does a Stock Based Compensation of $4.05 Mil mean?
Poniard Pharmaceuticals (PARD) has a Stock Based Compensation of $4.05 Mil as of Sep. 2011. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Poniard Pharmaceuticals and its competitors.
Is Poniard Pharmaceuticals' Stock Based Compensation too high?
Poniard Pharmaceuticals' current Stock Based Compensation is $4.05 Mil.
How does Poniard Pharmaceuticals' Stock Based Compensation compare to OBMP and NSPX?
Poniard Pharmaceuticals' Stock Based Compensation of $4.05 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Poniard Pharmaceuticals and its competitors. Poniard Pharmaceuticals's current Stock Based Compensation is $4.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poniard Pharmaceuticals stock overvalued right now?
Poniard Pharmaceuticals (PARD) has a current Stock Based Compensation of $4.05 Mil. The current Stock Based Compensation is $4.05 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Poniard Pharmaceuticals (PARD), the current Stock Based Compensation is $4.05 Mil as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poniard Pharmaceuticals Business Description

Address 300 Elliott Avenue West, Suite 530, Seattle, CA, USA, 98119
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.